Epigenetic modifications might also play a role, with MAGI2-AS3 potentially recruiting modifiers to regulate genes related to breast cancer development (Kai-Xin et al., 2021; Shaath et al., 2022). This evidence concerns the gene MAGI2 and breast cancer.